XML 22 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash Flows from Operating Activities    
Net loss $ (9,706,659) $ (21,862,716)
Net loss from discontinued operations (812,895) (10,559,963)
Net loss from continuing operations (8,893,764) (11,302,753)
Adjustments to reconcile net loss to net cash provided/(used) by operating activities:    
Depreciation and amortization 2,898,399 3,013,986
Gain/(loss) on disposal of property & equipment 37,910 471,019
Amortization of right-of-use assets 816,550
Change in allowance for inventory obsolescence 636,981
Change in allowance for doubtful accounts (265,203)
Amortization of original issue discounts on notes payable 944,778 108,222
Share-based compensation 191,416 622,232
Interest expense paid in equity shares 2,859,125 1,590,374
Income tax expense/(benefit) 2,073,835 (1,335,584)
Loss on equity interests 342,776
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Accounts receivable 37,390 3,082,635
Accounts receivable - related party (660,690) (61,799)
Inventory (2,223,632) 1,341,569
Prepaid expenses and other current assets 267,448 (240,732)
Other assets (246,350) (27,418)
Other liabilities (157,816) 1,221,549
Accounts payable (846,340) (2,114,250)
Operating lease liabilities (816,549)
Deposits from customers (3,414) (17,545)
Accrued expenses (4,820) (493,921)
Deferred revenue 195,775 228,024
Income taxes payable (121,191)
Net cash used by operating activities - continuing operations (3,280,162) (3,571,616)
Net cash provided/(used) by operating activities - discontinued operations (812,895) 7,507,090
Net cash provided/(used) by operating activities (4,093,057) 3,935,474
Cash Flows from Investing Activities    
Net change in self-insured benefit deposits (494,707) (1,659,480)
Purchase of property and equipment (1,566,014) 14,000
Purchase of marketable securities (475,016) (398,291)
Payments received on notes receivable 3,300,289  
Net cash provided/(used) by investing activities - continuing operations 764,552 (2,043,771)
Net cash provided by investing activities - discontinued operations 8,883,541
Net cash provided/(used) by investing activities 764,552 6,839,770
Cash Flows from Financing Activities    
Proceeds from notes payable 8,485,000 2,595,000
Payments on notes payable (851,640) (414,859)
Issuance of notes receivable (3,300,289)
Proceeds on bank loans 3,831,100
Payments on bank loans (778,090) (1,440,535)
Proceeds from securities purchase agreements 12,462,648
Expenses on securities purchase agreements (840,728)
Proceeds from at-the-market offerings 957,784
Expenses on at-the-market offerings (41,438)
Proceeds from the issuance of Series B Preferred Stock 500,000
Expenses from the issuance of Series B Preferred Stock (25,000)
Settlement of Series B Preferred Stock in cash   (273,092)
Revolving line of credit (425,812) (925,124)
Purchases of treasury stock (338,775)
Payments on capital lease liabilities (22,718) (24,286)
Net cash provided/used by financing activities - continuing operations 21,520,985 (2,391,839)
Net cash used by financing activities - discontinued operations (9,465,508)
Net cash provided/(used) by financing activities 21,520,985 (11,857,347)
Effect of currency translation 22,294 1,624,253
Net increase in cash, cash equivalents, and restricted cash 18,192,480 (1,082,103)
Cash, cash equivalents, and restricted cash at beginning of period 2,858,085 2,315,935
Cash, cash equivalents, and restricted cash at end of period 21,072,859 2,858,085
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and equivalents 19,490,061 1,769,994
Restricted cash 1,582,798 1,088,091
Total cash, cash equivalents, and restricted cash 21,072,859 2,858,085
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 1,590,541 715,722
Cash paid during the period for income taxes 32,345 162,871
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Investment in Vicon Technologies 500,000 300,000
Stock issued to pay for products and/or services 532,788
Stock issued to pay notes payable 8,737,125 5,047,569
Dividends paid in equity shares $ 2,170,990 $ 1,965,500